The integration of microarray information in the drug development process

In the past year, microarray technologies have moved beyond the proof-of-principle stage. Microarrays are now being used for genome-wide expression monitoring, large-scale polymorphism screening and mapping, and for the evaluation of drug candidates.

Saved in:
Bibliographic Details
Published in:Current opinion in biotechnology 1998-12, Vol.9 (6), p.643-649
Main Authors: Braxton, Scott, Bedilion, Tod
Format: Article
Language:English
Subjects:
Animals
Biotechnology - methods
Cell Line
Chromosome Mapping
Cloning, Molecular
Drug Design
Drug Therapy
Genetic Techniques
Humans
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the past year, microarray technologies have moved beyond the proof-of-principle stage. Microarrays are now being used for genome-wide expression monitoring, large-scale polymorphism screening and mapping, and for the evaluation of drug candidates.
ISSN:0958-1669
1879-0429
DOI:10.1016/S0958-1669(98)80144-4